Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeLevine Leichtman Capital PartnersLevine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC (“FlexXray” or the “Company”) to Warburg Pincus and Tilia Holdings. Financial terms of the transaction were not disclosed.

FlexXray is a leading provider of x-ray inspection services focused on food safety. The Company assists Fortune 100 food manufacturers with regulatory compliance and food safety issues by identifying and removing foreign contaminants. Hundreds of manufacturing plants throughout North America rely on FlexXray’s expertise and customer service to salvage valuable products when contamination events occur in the normal course of the food manufacturing process. FlexXray was founded in 2001 and is headquartered in Arlington, Texas.

Matthew Rich, Levine Leichtman Capital Partners

Matthew Rich, Senior Managing Director of LLCP, said, “Randy Jesberg and the entire FlexXray team have built an exceptional, differentiated business through an unwavering commitment to helping the world’s largest food manufacturers keep their products and their customers safe. Following our initial investment in 2017, the Company made significant investments in management, sales & marketing, technological capabilities, and capacity.  In addition, we were successful in completing two add-on acquisitions, which expanded FlexXray’s geographic reach, broadened its service offerings and enhanced its ability to better serve customers nationally. FlexXray is positioned for continued success under its new ownership.”

Randy Jesberg, CEO of FlexXray, commented, “We are appreciative of LLCP’s support and guidance over the last four years. Their partnership, management-centric approach and strategic insights contributed greatly to the evolution and expansion of the business. We could not have asked for a better partner to help guide FlexXray through this period of tremendous growth.”

The sale of FlexXray is LLCP’s seventh recent successful exit, following Trinity Consultants, Nothing Bundt Cakes, ZorgDomein, Jonathan Engineered Solutions, Futurewhiz and Pacific Handy Cutter.

Houlihan Lokey Capital, Inc. served as the lead financial advisor to FlexXray, with support from Robert W. Baird & Co., Incorporated, and Honigman LLP served as legal counsel in connection with the sale.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy